Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Minerva Neurosciences, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 20 | 20 | 0 |
| Shares | 2.40M | 2.42M | +12.4K (+0.5%) |
| Value | $16.6M | $14.9M | −$1.73M (−10.4%) |
New holders (2)
Institutions that held Minerva Neurosciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northern Trust Corp | 24,986 | $153.7K | 0.00% |
| Bank of America Corp | 128 | $787 | 0.00% |
Sold out (2)
Institutions that held Minerva Neurosciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Susquehanna International Group, LLP | 10,804 | $74.5K |
| JPMorgan Chase & Co | 9 | $62 |